EDGAR Filing Documents for 0001804591-24-000047

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001804591-24-000047

Filing Date

2024-08-08

Accepted

2024-08-08 16:11:14

Documents

Period of Report

2024-06-30

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	me-20240630.htm iXBRL	10-Q	1380702
2	EX-31.1	me-20240630xex311.htm	EX-31.1	10794
3	EX-31.2	me-20240630xex312.htm	EX-31.2	10843
4	EX-32.1	me-20240630xex321.htm	EX-32.1	5139
5	EX-32.2	me-20240630xex322.htm	EX-32.2	5418
	Complete submission text file	0001804591-24-000047.txt		8706471

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	me-20240630.xsd	EX-101.SCH	68088
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	me-20240630_cal.xml	EX-101.CAL	79217
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	me-20240630_def.xml	EX-101.DEF	393658
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	me-20240630_lab.xml	EX-101.LAB	805870
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	me-20240630_pre.xml	EX-101.PRE	603130
100	EXTRACTED XBRL INSTANCE DOCUMENT	me-20240630_htm.xml	XML	1217257

Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080

Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300

23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 241188401
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)